Flecainide and Pazopanib: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Flecainide
Pazopanib
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Increased flecainide exposure and increased risk of QT-interval prolongation
Interaction Deep Dive
Both flecainide, a CYP2D6 substrate1 with a narrow therapeutic index, and pazopanib, a weak CYP2D6 inhibitor, have been associated with QT-interval prolongation. Due to the potential for increased flecainide exposure and additive effects on the QT interval, concurrent use of flecainide with pazopanib is not recommended2. If concomitant use is required, close monitoring of cardiac function is warranted.
Why it happens (mechanism)
Inhibition of CYP2D6-mediated metabolism of flecainide by pazopanib; additive effects on QT interval
Common questions
Can I take Flecainide and Pazopanib together?
Increased flecainide exposure and increased risk of QT-interval prolongation Always confirm with your pharmacist or prescriber before making any change.
How serious is the Flecainide and Pazopanib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Flecainide or Pazopanib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
Keep reading about Flecainide
Keep reading about Pazopanib
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist